GSS 33 en es it fr

GSS 33 Brand names, GSS 33 Analogs

GSS 33 Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

GSS 33 Chemical_Formula


GSS 33 RX_link

No information avaliable

GSS 33 fda sheet

GSS 33 msds (material safety sheet)


GSS 33 Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

GSS 33 Molecular Weight

270.366 g/mol

GSS 33 Melting Point

254.5-256 oC

GSS 33 H2O Solubility

3 g/100mL

GSS 33 State


GSS 33 LogP


GSS 33 Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

GSS 33 Indication

For management of Menopausal and postmenopausal disorders

GSS 33 Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

GSS 33 Absorption


GSS 33 side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

GSS 33 Patient Information

GSS 33 Organisms Affected

Humans and other mammals